BioQuanti has signed an industry-academia cooperation agreement with a university in Central China to establish a Joint Immunoassay Laboratory.

The lab will focus on novel disease biomarker assay development and antibody candidate screening and validation, with research outcomes shared by both parties.

BioQuanti will provide reagents and an open experiment platform, while the university team contributes fundamental research support.